
November 13, 2017 - By Migdalia James
Causeway Capital Management Llc increased Baidu Inc (BIDU) stake by 4.3% reported in 2017Q2 SEC filing. Causeway Capital Management Llc acquired 154,836 shares as Baidu Inc (BIDU)’s stock rose 1.94%. The Causeway Capital Management Llc holds 3.76M shares with $672.40M value, up from 3.60M last quarter. Baidu Inc now has $81.23 billion valuation. The stock declined 1.32% or $3.14 reaching $234.26 on the news. About 15,910 shares traded. Baidu Inc (ADR) (NASDAQ:BIDU) has risen 12.02% since November 13, 2016 and is uptrending. It has underperformed by 4.68% the S&P500. Astrazeneca Plc (NYSE:AZN) had a decrease of 11.84% in short interest. AZN’s SI was 14.88 million shares in November as released by FINRA. Its down 11.84% from 16.88 million shares previously. With 3.58M avg volume, 4 days are for Astrazeneca Plc (NYSE:AZN)’s short sellers to cover AZN’s short positions. The SI to Astrazeneca Plc’s float is 0.6%. About 105,789 shares traded. AstraZeneca plc (ADR) (NYSE:AZN) has risen 19.45% since November 13, 2016 and is uptrending. It has outperformed by 2.75% the S&P500.Causeway Capital Management Llc decreased Carnival Plc (NYSE:CUK) stake by 36,732 shares to 255,030 valued at $16.86M in 2017Q2. It also reduced Tal Ed Group (NYSE:XRS) stake by 6,600 shares and now owns 25,600 shares. Ubs Group Ag (NYSE:UBS) was reduced too. Among 24 analysts covering Baidu (NASDAQ:BIDU), 9 have Buy rating, 4 Sell and 11 Hold. Therefore 38% are positive. Baidu had 55 analyst reports since July 28, 2015 according to SRatingsIntel. The stock of Baidu Inc (ADR) (NASDAQ:BIDU) earned “Underweight” rating by JP Morgan on Wednesday, August 31. Credit Suisse downgraded the shares of BIDU in report on Friday, October 28 to “Neutral” rating. The firm has “Neutral” rating by JP Morgan given on Monday, January 9. The stock of Baidu Inc (ADR) (NASDAQ:BIDU) earned “Hold” rating by TH Capital on Friday, July 29. The rating was maintained by Jefferies with “Buy” on Friday, October 20. The stock of Baidu Inc (ADR) (NASDAQ:BIDU) has “Underperform” rating given on Wednesday, January 11 by Bernstein. The stock has “Underperform” rating by Credit Agricole on Tuesday, July 28. The rating was initiated by Cantor Fitzgerald with “Underweight” on Monday, December 19. The firm earned “Buy” rating on Friday, April 29 by Brean Capital. The rating was initiated by Wells Fargo with “Buy” on Tuesday, September 26.AstraZeneca PLC is a biopharmaceutical company. The company has market cap of $81.03 billion. The Firm focuses on discovery and development of products, which are then manufactured, marketed and sold. It has a 23.45 P/E ratio. The Firm focuses on three main therapy areas: Oncology, Cardiovascular & Metabolic Disease (CVMD) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience.Among 24 analysts covering AstraZeneca plc (ADR) (NYSE:AZN), 14 have Buy rating, 0 Sell and 10 Hold. Therefore 58% are positive. AstraZeneca plc (ADR) had 39 analyst reports since July 31, 2015 according to SRatingsIntel. Bryan Garnier & Cie upgraded the shares of AZN in report on Friday, September 18 to “Buy” rating. The rating was downgraded by Leerink Swann to “Hold” on Thursday, July 27. BNP Paribas downgraded the stock to “Neutral” rating in Wednesday, September 14 report. Bernstein upgraded the shares of AZN in report on Friday, September 22 to “Outperform” rating. The stock of AstraZeneca plc (ADR) (NYSE:AZN) has “Buy” rating given on Monday, October 16 by Credit Suisse. HSBC upgraded AstraZeneca plc (ADR) (NYSE:AZN) on Wednesday, September 2 to “Buy” rating. The stock has “Hold” rating by Nordea on Monday, November 2. Liberum Capital upgraded the shares of AZN in report on Friday, November 25 to “Buy” rating. UBS downgraded the shares of AZN in report on Wednesday, April 5 to “Neutral” rating. The firm has “Buy” rating given on Wednesday, August 9 by Piper Jaffray.Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.


var data = "63557954";
document.write('<ins class="adsbygoogle" style="background-color:transparent; display:inline-block;width:300px;height:600px;" data-ad-client="ca-pub-16900'+data+'675" data-ad-slot="7169126944"></ins>')

(adsbygoogle = window.adsbygoogle || []).push({});